Wednesday, June 25, 2014

Genetic Testing for Macular Degeneration (AMD)

Genetic test for age related macular degeneration (AMD) has gotten a great deal of attention in the recent past. While the presence of specific genes may indicate a increased risk for age related macular degeneration (AMD), according to researchers commenting in the Ophthalmology routine genetic testing to predict the development of age related macular degeneration (AMD) does not really predict how a person would respond to Vascular Endothelial Growth Factor (VEGF) Inhibitor injections and thus the genetic testing is not recommended. Further, the downside of routine genetic testing at present is that it can cause unnecessary anxiety, it can leave patients with promises that are not fulfilled and it may impact insurability and employability.

If you or someone you know is concerned about age related macular degeneration (AMD) risk or has any family history of AMD they are encouraged to schedule regular eye examinations at D’Ambrosio Eye Care by calling us at 800-325-3937, visiting D’Ambrosio Eye Care or facebook.com/dambrosioeyecare so that we can help recommend an appropriate treatment plan.

D'Ambrosio Eye Care is a leading eye and LASIK care practice with office locations at 479 Old Union Turnpike, Lancaster, Massachusetts 01523, 100 Powder Mill Road, Acton, Massachusetts 01720, 413 Main Street, Athol, Massachusetts 01331 and 74 Main Street,Gardner, Massachusetts 01440 that serve the greater Boston and central Massachusetts area.

Tuesday, June 3, 2014

CRP Proteins Indicate Risk of Macular Degeneration

We are always looking for ways to predict the risk that patients have of various eye diseases. We now know that the risk of age related macular degeneration (AMD) is correlated with the findings of the CRP (c-reactive proteins) test in men and women according to researchers from Harvard Medical School and Brigham and Women’s Hospital in Boston who reported in JAMA Ophthalmology.

The findings of this study showed that there was a significantly increased risk of AMD for those patients with high versus low CRP levels and those with high CRP levels also had a significantly increased risk of neovascular or Wet AMD-a potential cause of catastrophic vision loss. The researchers concluded that elevated levels of CRP predict greater future risk of AMD. It is believed that this information might shed light on underlying mechanisms and could be of clinical help in the identification of persons at high risk of AMD who may benefit from increased adherence to lifestyle recommendations, eye examination schedules and therapeutic protocols.

If you or someone you know is concerned about age related macular degeneration (AMD) risk or has any family history of AMD they are encouraged to schedule regular eye examinations at D’Ambrosio Eye Care by calling us at 800-325-3937, visiting D’Ambrosio Eye Care or facebook.com/dambrosioeyecare so that we can help recommend an appropriate treatment plan.

D'Ambrosio Eye Care is a leading eye and LASIK care practice with office locations at 479 Old Union Turnpike, Lancaster, Massachusetts 01523, 100 Powder Mill Road, Acton, Massachusetts 01720, 413 Main Street, Athol, Massachusetts 01331 and 74 Main Street, Gardner, Massachusetts 01440.